throbber
ELSEVIER
`
`Journal of the European Academy of Dermatology and Venereology
`4 (Suppl. 1) (1995) S17-$21
`
`JEADV
`
`Amorolfine nail lacquer: a novel formulation
`
`Unitd de Recherche en Dermopharmacologie et Cosmdtologie, Facultd de Pharmacie, Unit’ersitd Paris Sud, 5 rue J.B. Cldment,
`92296 Chdtenay-Malabry, France
`
`Jean-Paul L. Marty *
`
`Abstract
`
`Onychomycosis is difficult to treat. Systemic therapy with the potent oral azoles may be restricted by
`their potential side-effects; an attractive alternative is topical application of an antifungal directly to the
`nail. Several such formulations have been developed, including creams and lotions which arc largely
`ineffective due to poor drug penetration into and through the nail structure. Nail keratin is thick and
`compact; its permeability is low. Transungual drug diffusion depends on the characteristics of the nail
`(especially degree of hydration) and the properties of the chemical (molecular weight and size, and
`lipophilic/hydrophilic profile). A nail lacquer containing 5% amorolfine was recently introduced; the
`volatile vehicle evaporates, leaving an occlusive film on the surface of the nail. The film acts as a drug
`depot, while at the same time increasing the hydration of the nail and the thermodynamic activity of the
`drug, thereby enhancing diffusion, particularly of hydrophilic compounds. Amorolfinc has been shown to
`penetrate human nail from the film at clinically effective concentrations. In addition, the effect is long
`lasting: a single application of lacquer provides protection for 1 week. Release and rate of diffusion can
`be optimized by selecting the components of the lacquer formulation (solvent, polymer, plasticizer).
`Transungual drug delivery via nail lacquer is a major addition in the dermatologist’s therapeutic arsenal.
`
`Keywords: Amorolfine; Nail lacquer; Transungual drug delivery; Nail diffusion
`
`1. Introduction
`
`Successful local therapy of onychomycosis is
`dependent on choosing an appropriate antifungal
`coupled with a method of delivery which maxi-
`
`* Corresponding author. Tel.: + 33 1 4683 5351.
`
`mizes the effect of the active principle by aiding
`its diffusion into the nail bed at levels exceeding
`the minimum inhibitory concentration (MIC)
`against local infection by fungi, dermatophytes
`and molds.
`Local treatments are an interesting alternative
`to long-term systemic therapy, especially when
`the nail matrix is not affected. Transungual diffu-
`sion of the active principle is the necessary and
`
`0926-9959/95/$09.50 © 1995 Elsevier Science B.V. All rights reserved
`SSD1 0926-9959(94)00075-1
`
`ARGENTUM EX1030
`
`Page 1
`
`

`

`S18
`
`J.-P.L. Marty /J. Eur. Acad. Dermatol. VenereoL 4 (Suppl. 1) (1995) S17-$21
`
`limiting condition for all local application¯ Diffu-
`sion depends on the physicochemical composition
`of the nail and of the excipient containing the
`active principle¯
`In addition to delivery of the active principle
`to the nail, other problems exist in applying drugs
`to the nail surface: how to apply the preparation
`evenly, how to maintain it in place long enough to
`ensure adequate penetration at fungicidal levels,
`and thereby avoiding multiple applications and
`enhance compliance¯
`
`2. Differential permeability of nail
`
`The basic constituent of the nail is keratin, a
`scleroprotein responsible for the mechanical re-
`sistance of the nails¯ The hardness of the nail
`plate depends not only on the junctions between
`the cells and their architectural arrangement, but
`also on the tranverse orientation of the keratin
`filaments with respect to the axis of nail growth¯
`The multiplicity of the lateral bonds between
`keratin fibers (disulfide bridges, hydrogen bonds,
`acid-base bonds, electrostatic bonds) accounts for
`the hardness of nail keratin and its high resis-
`tance to the diffusion of active principles.
`Nail contains little lipid (0.5 to 1.5%, depend-
`ing on age), in contrast to the stratum corneum
`(10%) [1]. The lipid comprises cholesterol, which
`appears to be responsible for maintaining nail
`elasticity and cell cohesion, hydrocarbons and
`mainly unsaturated fatty acids. The latter account
`for 2/3 of the total lipid, and consist mainly of
`oleic acid. Phospholipids tend to be found in
`abundance in the dorsal layer of the nail, in
`association with calcium. Solvent extraction of
`cholesterol leaves the nail dry and brittle¯
`Water is the main nail plasticizer¯ Its concen-
`tration in nail tissue (7% to 12%) is directly
`related to ambient relative humidity, and is lower
`than in the stratum corneum (15% to 25% under
`normal conditions). In dry air, nails quickly lose
`water; they can be rehydrated up to a maximum
`concentration of 25% in high ambient humidity.
`Nail is less able to bind water than the stratum
`corneum, which can absorb several times its dry
`weight [1,2].
`
`Like the stratum corneum, nail tissue is con-
`stantly losing water; under normal conditions,
`transungual diffusion of water (1.8 to 3.1 mg/cm2
`¯ h) is similar to transepidermal water loss from
`the palms and soles (2.0 to 3.0 mg/cm2’ h). It is
`10-fold higher than that from other anatomical
`areas (0.15 to 0.35 mg/cm2’ h). Given the rela-
`tive thicknesses of stratum corneum and nail, the
`permeability of nail to water is some 1000-fold
`greater than that of the stratum corneum [3,4].
`The nail plate is also permeable to many polar
`and non-polar substances with widely differing
`molecular weights (30 to 665), as shown in toxico-
`logical studies (formaldehyde, phenol, fluoruraciI,
`detergents, pesticides, mercurials, hydroquinone
`etc), therapeutic trials (antifungal agents, antipso-
`riasis drugs) and diffusion studies [5].
`Aliphatic alcohols are useful for analysing the
`mechanism of diffusion across biological mem-
`branes, owing to their respective solubility in wa-
`ter and lipids. The data reported by Waiters et al.
`for dilute aqueous solutions of these alcohols
`with samples of human nail in vitro show that the
`permeability constant falls steadily from methanol
`to octanol, and then rises up to decanol. These
`results differ from those obtained with the same
`substances under identical experimental condi-
`tions in stratum corneum, in which membrane
`permeability increases with the length of the hy-
`drocarbon chain [6].
`These comparative data suggest that the stra-
`tum corneum is a lipophilic membrane; the in-
`crease in diffusion is due to a favorable partition
`coefficient of lipophilic alcohols in the hydropho-
`bic areas of the membrane¯ Nail, on the other
`hand, behaves primarily as a water gel (for alco-
`hols comprising 1 to 8 carbon atoms)¯ A lipophilic
`route of diffusion has been demonstrated for the
`diffusion of alcohols with a longer hydrocarbon
`chain¯ Similar qualitative data have been ob-
`tained when aliphatic alcohols have been applied
`pure to the nail surface and not in dilute aqueous
`solution. However, permeability constants are on
`average five times lower than those obtained with
`the dilute aqueous solutions. The parallel diffu-
`sion profiles show that the concentration of the
`diffusing molecule is a predominant factor in the
`mechanism; the difference in degree of diffusion
`
`Page 2
`
`

`

`J.-P.L. Marty /J. Eur. Acad. Dermatol, Venereol. 4 (Suppl. 1) (1995) S17-$2l
`
`S19
`
`suggests that water facilitates diffusion through
`the nail [7].
`This physicochemical difference in the charac-
`teristics of nail permeability suggests that there
`are two routes by which substances penetrate
`nails:
`
`-The hydrophilic pathway, which is used by
`most compounds, particularly if polar, and
`which accounts for the diffusion of water, urea,
`electrolytes and the ionized forms of ionizable
`molecules; the water contained in the vehicle
`plays an important role in promoting diffusion.
`- A secondary lipophilic pathway, through the
`extracellular lipid network, for use by strictly
`non-polar compounds.
`
`This selective diffusion of hydrophilic substances
`through a water gel contrasts with that in the
`stratum corneum and restricts the diffusion of
`many active principles that were developed for
`dermatological use because their lipophilic prop-
`erties enabled them to diffuse through the extra-
`cellular lipids of the stratum corneum [8].
`The excipients developed for use on skin are
`thus inappropriate for releasing active principles
`on the nail, as shown by the inefficacy of diffu-
`sion promoters such as DMSO [9]. Where ioniz-
`able substances are concerncd, water solubility is
`maximal when ionization is complete; given that
`the nail is hydrophilic, vehicle pH can thus play a
`fundamental role, as has been suggested in the
`case of miconazole [10], where a high concentra-
`tion of active principle is achieved in the vehicle
`for maximal diffusion.
`
`3. Transungual drug diffusion
`
`The topical formulations conventionally used
`in dermatology (creams, gels, water- or oil-based
`lotions, powders) are specifically adapted neither
`to the nail nor to the mean treatment duration (6
`to 12 months) required for the growth of a healthy
`nail. Following application to the nail, such for-
`mulations are readily removed by rubbing, wiping
`and washing; their impermanence at the site of
`application readily accounts for their inefficacy.
`
`Apparently simple formulations have been pro-
`posed instead: alcoholic solutions containing high
`concentrations of active principle, e.g. 28%
`ticonazole, and nail lacquers or film-generating
`solutions containing 8% ciclopirox or 5%
`amorolfine.
`A film-generating solution is a novel therapeu-
`tic formulation developed to deliver effcctivc
`doses of antifungal to the entire nail tissue over a
`short duration (one day, in the case of cielopirox)
`or for longer periods (up to 1 week, in the case of
`amorolfine). Because 5% amorolfine remains at
`the site of application, the number of applications
`can be reduced, while effective treatment is en-
`sured by high bioavailability of the active princi-
`ple.
`A film-generating solution basicaIly consists, in
`addition to the active agent, of the following: a
`volatile solvent (ethanol, ethyl/butyl/methyl ac-
`etate, methylene chloride, methyl ethyl ketone,
`isopropanol) and a non-water-soluble polymer
`(methacrylic acid copolymers, vinyl polymers)
`which leaves a thin continuous film following
`evaporation of the solvent. Plasticizers (triacetin,
`dibutyl phthalatc) can be added to give the film
`the characteristics required for molding to the
`nail, including enough mechanical flexibility to
`prevent flaking and removal. The solvent itself
`can be composed of a mixture of compounds to
`accelerate drying and result in an even and repro-
`ducible film.
`This formulation is very similar to that of a
`nail lacquer, one of the most widely used prod-
`ucts in cosmetics. It maintains the active principle
`in a polymer film depot on the nail surface, from
`which the antifungal evenly diffuses through the
`nail plate keratin to reach the nail bed. The
`concentration (or thermodynamic activity) of the
`active principle in the film after solvent evapora-
`tion is extremely high; by the laws of diffusion,
`this enhances penetration [8].
`According to Spruit [11], application of an 0.05
`mm film of nail lacquer reduces transungual wa-
`ter diffusion from 1.6 to 0.4 mg/cm2’ h, leading
`to hyperhydration of the upper layers of the nail
`plate. This also enhances the diffusion of the
`amorolfine applied to the nail surface.
`The specific aims addressed in formulating a
`
`Page 3
`
`

`

`$20
`
`J.-P.L. Marty /J. Eur. Acad. DermatoL Venereol. 4 (Suppl. 1) (1995) S17-$21
`
`film-generating solution were to give the active
`principle maximal affinity for nail keratin and
`obtain the highest possible thermodynamic activ-
`ity compatible with maintaining the active princi-
`ple in true or supersaturated solution. Thus, in
`the case of Loceryl°rM, the amorolfine concentra-
`tion in the film-generating solution is 5%; solvent
`evaporation leaves a film with a final amorolfine
`concentration of 25%. The high post-evaporation
`concentration enhances transungual diffusion of
`the active principle.
`The concern to maximize diffusion must take
`into account the stability of the active principle
`and any physicochemical incompatibilities. The
`final product must be as clinically effective as
`possible, at the same time as having a maximal
`risk/benefit ratio and zero systemic diffusion.
`This means that the vehicle constituents must be
`non-irritant and non-allergenic and be well toler-
`ated locally. The formulation chemist is also un-
`der purely technological constraints arising from
`the use of organic solvents: special techniques
`need to be employed, particularly in the choice of
`inner packaging, to ensure maximal stability dur-
`ing storage. Application of the lacquer to the nail
`surface requires a device coping with the viscosity
`of the solution and giving a consistent and repro-
`ducible dose. A calibrated spatula gives a uniform
`coat of 18/xl of solution per nail; thus 90 + 8 /zl
`(mean + standard deviation) is required to treat
`five nails.
`The film-generating solution, in the case of
`amorolfine, is an excipient giving substantial in-
`traungual diffusion, which is enhanced by the
`hydrating effect of the film; the active principle
`penetrates rapidly following a single application.
`Thus 6 h after single application in vitro, the nail
`concentration of amorolfine is 56/xg/g ¯ cm2, with
`a residual concentration of 188 /xg/g. cm2 after
`7 days. These tissue concentrations are 140- and
`470-fold higher, respectively, than the MIC
`against Candida albicans [12]. The vehicIe compo-
`sition helps modulate the release of amorolfine
`into the nail and maintain it at high levels over 7
`days [13]. These data have been confirmed in
`vivo, after treatment for one month: two weeks
`after the last application, subungual tissue still
`
`showed an overall antifungal activity far exceed-
`ing the mean MICs against test organisms [14].
`
`4. Conclusion
`
`A nail lacquer is a novel formulation solution
`to the problem of a transungual drug delivery
`system for maximal antifungal efficacy. The film
`on the nail surface acts as a depot of active
`principle, permitting optimized and sustained dif-
`fusion of amorolfine (for up to 7 days). Continu-
`ous penetration of the active principle leads to
`the high tissue concentrations required for the
`effective treatment of onychomycosis.
`
`References
`
`[1] Baden HP, Goldsmith LA, Fleming B. A comparative
`study of the physieoehemical properties of human kera-
`tinized tissues. Biochim Biophys Acta 1973;322:269-278.
`[2] Finlay AY, Frost P, Keith AD, Snipes W. An assessment
`
`of factors influencing flexibility of human fingernails. Br
`J Dermatol 1980;103:357-365.
`[3] Spruit D. Measurement of water vapor loss through
`human nail in vivo. J Invest Dermatol 1971;56:359-361.
`[4] Waiters KA, Flynn GL, Marvel JR. Physicochemical
`
`characterization of the human nail: 1. Pressure scaled
`apparatus for measuring nail plate permeability. J Invest
`Dermatol 1981;76:76-79.
`[5] Waiters KA, Flynn GL. Permeability characteristics of
`the human nail plate. Int J Cosmet Sci 1983;5:231-246.
`[6] Walters KA, Flynn GL, Marvel JR. Physicoehemieal
`characterization of the human nail: Permeation pattern
`for water and the homologous alcohols and differences
`with respect to the stratum corneum. J Pharm Pharmacol
`1983;35:28-33.
`[71 Walters KA, Flynn GL, Marvel JR. Physicochemical
`characterization of the human nail: Solvent effects on the
`permeation of homologous alcohols. J Pharm Pharmaeol
`1985;37:771-775.
`[8] Marry JP, Dervault AM. Voie percutan~e, ln: Dubertret
`L (ed.), Th4rapeutique dermatologique. Paris: M4decine
`Sciences Flammarion, 1991;649-663.
`[9] Walters KA. Penetration of chemicals into, and through,
`the nail plate. Pharm Int 1985;April:85-89.
`[10] Waiters KA, Flynn GL, Marvel JR. Penetration of the
`human nail plate: the effects of vehicle pH on the perme-
`ation of miconazole. J Pharm Pharmacol 1985;37:498-
`499.
`[11] Spruit D. Effect of nail polish on the hydration of the
`fingernail. Amer Cosmet Perf 1972;87:57-58.
`
`Page 4
`
`

`

`J.-P.L. Marry/J. Eur Acad. Derrnatol. Venereol. 4 (Suppl. 1) (1995) S17-$21
`
`$21
`
`[12] Pittrof F, Gerhards J, Erni W, Kleeak G. LocerylTM nail
`lacquer: realization of a new galenical approach to ony-
`chomycosis therapy. Clin Exp Dermatol 1992;17(suppl
`1):26-28.
`[13] Franz TJ. Absorption of amorolfine through human nail.
`Dermatology 1992;184(suppl 1):18-20.
`
`[14] Mensing 1t, Polak-Weiss A, Splanemann V. Determina-
`tion of the subungual antifungal activity of amorolfine
`after 1 month’s treatment in patients with onyehomyco-
`sis: comparison of two nail lacquer formulations. Clin
`Exp Dermatol 1992;17(supp[ I):29-32.
`
`Page 5
`
`

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket